STOCK TITAN

NEXGEL to Report its First Quarter 2022 Financial and Operating Results on May 12, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

NEXGEL, a provider of high-water-content hydrogel products, will announce its first quarter 2022 financial and operating results on May 12, 2022, after market closure. A conference call is scheduled for 4:30 PM/ET on the same day to discuss these results. The call can be accessed via toll-free numbers and will be webcast live, with an archive available for 90 days. The company specializes in skin-friendly hydrogels, developing over 200 combinations using natural ingredients for long-term wear with minimal irritation.

Positive
  • None.
Negative
  • None.

Management will host a conference call at 4:30 PM/ET on the same day

LANGHORNE, Pa., May 9, 2022 /PRNewswire/ -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced that it will report its financial and operating results for the first quarter of 2022 after the market closes on May 12, 2022. 

Following the release of its financial and operating results, the Company will host a conference call at 4:30 PM/ET on May 12, 2022, to discuss the results. The conference call will be webcast live and can be accessed by registering on the Events and Presentations portion of NEXGEL's Investor Relations website. The webcast will be archived for approximately 90 days.

NEXGEL First Quarter 2022 Results Conference Call

Date: May 12, 2022

Time: 4:30 PM/ET

Live Call: 1-877-270-2148 (U.S. Toll Free) or + 1-412-902-6510 (International)

Webcast: https://services.choruscall.com/mediaframe/webcast.html?webcastid=jP97vpF5

For interested individuals unable to join the conference call, a replay will be available through August 12, 2022, at + 1-877-344-7529 (U.S. Toll Free) or 1-412-317-0088 (International). Participants must use the following code to access the replay of the call: 9940170. An archived version of the webcast will also be available on NEXGEL's Investor Relations site: https://ir.nexgel.com/.

About NEXGEL, INC.
NEXGEL is a leading provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. Alongside its strategic partners, NEXGEL has formulated more than 200 different combinations to bring natural ingredients to gentle skin patches that can be worn for long periods of time with little to no irritation.

Investor Contacts:
Valter Pinto
KCSA Strategic Communications
212.896.1254
valter@kcsa.com

Media Contacts:
Raquel Cona
KCSA Strategic Communications
212.896.1204
rcona@kcsa.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nexgel-to-report-its-first-quarter-2022-financial-and-operating-results-on-may-12-2022-301542282.html

SOURCE NEXGEL

FAQ

When will NEXGEL report its first quarter 2022 results?

NEXGEL will report its first quarter 2022 financial and operating results on May 12, 2022, after the market closes.

What time is the NEXGEL conference call scheduled for?

The NEXGEL conference call is scheduled for 4:30 PM/ET on May 12, 2022.

How can I access the NEXGEL conference call?

You can access the NEXGEL conference call by calling 1-877-270-2148 (U.S. Toll Free) or +1-412-902-6510 (International).

Is there a webcast for the NEXGEL conference call?

Yes, the NEXGEL conference call will be webcast live and can be accessed through their Investor Relations website.

How long will the NEXGEL conference call replay be available?

A replay of the NEXGEL conference call will be available until August 12, 2022.

NexGel, Inc

NASDAQ:NXGL

NXGL Rankings

NXGL Latest News

NXGL Stock Data

32.49M
5.28M
20.09%
2.95%
0.4%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
LANGHORNE